TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10859871
log Bayes Factor = 0.0967619
Chromosome 12   position 95,711,876  (GRCh37) Explore rs10859871 on Ensembl!
Variant rs10859871 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
F41.9 Anxiety disorder, unspecified
0.000 0.704 0.296
F41 Other anxiety disorders
0.000 0.712 0.288
F41.2 Mixed anxiety and depressive disorder
0.000 0.721 0.279
F41.0 Panic disorder [episodic paroxysmal anxiety]
0.000 0.725 0.275
F41.8 Other specified anxiety disorders
0.000 0.778 0.222
F41.3 Other mixed anxiety disorders
0.000 0.786 0.214
F40-F48 Neurotic, stress-related and somatoform disorders
0.000 0.868 0.132
F43 Reaction to severe stress, and adjustment disorders
0.000 0.884 0.116
F40 Phobic anxiety disorders
0.000 0.897 0.103
F43.1 Posttraumatic stress disorder
0.000 0.900 0.100
F43.2 Adjustment disorders
0.000 0.902 0.098
F40.2 Specific (isolated) phobias
0.000 0.903 0.097
F44 Dissociative [conversion] disorders
0.000 0.906 0.094
F43.9 Reaction to severe stress, unspecified
0.000 0.911 0.089
F41.1 Generalised anxiety disorder
0.000 0.915 0.085
F42 Obsessive-compulsive disorder
0.000 0.915 0.085
F43.8 Other reactions to severe stress
0.000 0.917 0.083
F48 Other neurotic disorders
0.000 0.918 0.082
F44.9 Dissociative [conversion] disorder, unspecified
0.000 0.920 0.079
F45 Somatoform disorders
0.000 0.922 0.078
F40.1 Social phobias
0.000 0.926 0.074
F40.8 Other phobic anxiety disorders
0.000 0.928 0.072
E10.1 With ketoacidosis
0.000 0.930 0.070
F44.8 Other dissociative [conversion] disorders
0.000 0.933 0.067
F44.7 Mixed dissociative [conversion] disorders
0.000 0.933 0.067
F44.6 Dissociative anaesthesia and sensory loss
0.000 0.933 0.067
F44.3 Trance and possession disorders
0.000 0.933 0.067
F44.2 Dissociative stupor
0.000 0.933 0.067
F44.1 Dissociative fugue
0.000 0.933 0.067
F44.0 Dissociative amnesia
0.000 0.933 0.067
E10 Insulin-dependent diabetes mellitus
0.000 0.934 0.066
E10.3 With ophthalmic complications
0.000 0.936 0.064
E10.2 With renal complications
0.000 0.939 0.061
F42.8 Other obsessive-compulsive disorders
0.000 0.939 0.061
F42.2 Mixed obsessional thoughts and acts
0.000 0.939 0.061
F42.1 Predominantly compulsive acts [obsessional rituals]
0.000 0.939 0.061
F43.0 Acute stress reaction
0.000 0.940 0.060
F40.0 Agoraphobia
0.000 0.941 0.059
F48.8 Other specified neurotic disorders
0.000 0.941 0.059
F48.1 Depersonalisation-derealisation syndrome
0.000 0.941 0.059
F44.4 Dissociative motor disorders
0.000 0.942 0.058
F45.4 Persistent somatoform pain disorder
0.000 0.942 0.058
F45.0 Somatisation disorder
0.000 0.942 0.058
F48.0 Neurasthenia
0.000 0.942 0.057
F42.0 Predominantly obsessional thoughts or ruminations
0.000 0.943 0.057
F45.1 Undifferentiated somatoform disorder
0.000 0.944 0.056
F45.3 Somatoform autonomic dysfunction
0.000 0.944 0.056
F44.5 Dissociative convulsions
0.000 0.944 0.056
F42.9 Obsessive-compulsive disorder, unspecified
0.000 0.944 0.055
F45.2 Hypochondriacal disorder
0.000 0.945 0.055
F45.9 Somatoform disorder, unspecified
0.000 0.946 0.053
E10.0 With coma
0.000 0.947 0.053
E10.5 With peripheral circulatory complications
0.000 0.949 0.051
E10.9 Without complications
0.000 0.951 0.049
F48.9 Neurotic disorder, unspecified
0.000 0.952 0.048
E10.7 With multiple complications
0.000 0.952 0.048
F40.9 Phobic anxiety disorder, unspecified
0.001 0.953 0.046
E10.8 With unspecified complications
0.000 0.953 0.047
E10.6 With other specified complications
0.000 0.954 0.046
F45.8 Other somatoform disorders
0.000 0.961 0.039
E10.4 With neurological complications
0.000 0.966 0.034
D17.6 Benign lipomatous neoplasm of spermatic cord
0.024 0.976 0.000
T42.4 Benzodiazepines
0.000 0.978 0.022
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.982 0.018
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.983 0.017
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.985 0.015
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.987 0.013
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.987 0.013
T42.3 Barbiturates
0.000 0.987 0.013
T42.2 Succinimides and oxazolidinediones
0.000 0.987 0.013
T42.1 Iminostilbenes
0.000 0.988 0.012
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.989 0.011
C71 Malignant neoplasm of brain
0.000 0.989 0.011
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.989 0.011
Z48.0 Attention to surgical dressings and sutures
0.000 0.989 0.011
C71.9 Brain, unspecified
0.000 0.990 0.010
C71.0 Cerebrum, except lobes and ventricles
0.000 0.990 0.010
T40.6 Other and unspecified narcotics
0.000 0.990 0.010
C71.2 Temporal lobe
0.000 0.990 0.010
Z93.2 Ileostomy status
0.000 0.990 0.010
T40.4 Other synthetic narcotics
0.000 0.990 0.010
C71.3 Parietal lobe
0.000 0.990 0.010
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.990 0.009
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.991 0.009
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.991 0.009
C71.4 Occipital lobe
0.000 0.991 0.009
T45.5 Anticoagulants
0.000 0.991 0.009
T42.0 Hydantoin derivatives
0.000 0.991 0.008
C71.8 Overlapping lesion of brain
0.000 0.992 0.008
T39.0 Salicylates
0.000 0.992 0.008
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.992 0.008
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.992 0.008
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.992 0.008
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.992 0.008
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.992 0.008
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.992 0.008
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.992 0.008
C71.7 Brain stem
0.000 0.992 0.008
C71.6 Cerebellum
0.000 0.992 0.008
C71.5 Cerebral ventricle
0.000 0.992 0.008
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.992 0.008
T40.8 Lysergide [LSD]
0.000 0.992 0.008
T40.7 Cannabis (derivatives)
0.000 0.992 0.008
T40.3 Methadone
0.000 0.992 0.008
T40.0 Opium
0.000 0.992 0.008
T45.2 Vitamins, not elsewhere classified
0.000 0.992 0.008
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.992 0.008
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.992 0.007
T40.5 Cocaine
0.000 0.992 0.007
T40.1 Heroin
0.000 0.993 0.007
T40.2 Other opioids
0.000 0.993 0.007
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.993 0.007
T45.8 Other primarily systemic and haematological agents
0.000 0.993 0.007
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.993 0.007
T45.6 Fibrinolysis-affecting drugs
0.000 0.993 0.007
T45.4 Iron and its compounds
0.000 0.993 0.007
T45.3 Enzymes, not elsewhere classified
0.000 0.993 0.007
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.993 0.007
T39.4 Antirheumatics, not elsewhere classified
0.000 0.993 0.007
T39.2 Pyrazolone derivatives
0.000 0.993 0.007
M10.99 Gout, unspecified (Site unspecified)
0.007 0.993 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.993 0.007
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.993 0.007
T36 Poisoning by systemic antibiotics
0.000 0.993 0.006
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.993 0.006
T38.1 Thyroid hormones and substitutes
0.000 0.993 0.006
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.994 0.006
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.994 0.006
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.994 0.006
T46.7 Peripheral vasodilators
0.000 0.994 0.006
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.994 0.006
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.994 0.006
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.994 0.006
T38.9 Other and unspecified hormone antagonists
0.000 0.994 0.006
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.994 0.006
T38.7 Androgens and anabolic congeners
0.000 0.994 0.006
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.994 0.006
T38.5 Other oestrogens and progestogens
0.000 0.994 0.006
T38.4 Oral contraceptives
0.000 0.994 0.006
T38.2 Antithyroid drugs
0.000 0.994 0.006
T38.0 Glucocorticoids and synthetic analogues
0.000 0.994 0.006
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.994 0.006
T48.5 Anti-common-cold drugs
0.000 0.994 0.006
T48.4 Expectorants
0.000 0.994 0.006
T48.3 Antitussives
0.000 0.994 0.006
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.994 0.006
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.994 0.006
T48.0 Oxytocic drugs
0.000 0.994 0.006
T41.5 Therapeutic gases
0.000 0.994 0.006
T41.4 Anaesthetic, unspecified
0.000 0.994 0.006
T41.3 Local anaesthetics
0.000 0.994 0.006
T41.2 Other and unspecified general anaesthetics
0.000 0.994 0.006
T41.1 Intravenous anaesthetics
0.000 0.994 0.006
T41.0 Inhaled anaesthetics
0.000 0.994 0.006
T49.9 Topical agent, unspecified
0.000 0.994 0.006
T49.8 Other topical agents
0.000 0.994 0.006
T49.7 Dental drugs, topically applied
0.000 0.994 0.006
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.994 0.006
T49.5 Ophthalmological drugs and preparations
0.000 0.994 0.006
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.994 0.006
T49.3 Emollients, demulcents and protectants
0.000 0.994 0.006
T49.2 Local astringents and local detergents
0.000 0.994 0.006
T49.1 Antipruritics
0.000 0.994 0.006
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.994 0.006
T47.0 Histamine H(2)-receptor antagonists
0.000 0.994 0.006
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.994 0.006
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.994 0.006
T47.7 Emetics
0.000 0.994 0.006
T47.5 Digestants
0.000 0.994 0.006
T47.3 Saline and osmotic laxatives
0.000 0.994 0.006
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.994 0.006
T46.1 Calcium-channel blockers
0.000 0.994 0.006
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.994 0.006
T37.5 Antiviral drugs
0.000 0.994 0.006
T37.4 Anthelminthics
0.000 0.994 0.006
T37.3 Other antiprotozoal drugs
0.000 0.994 0.006
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.994 0.006
T37.1 Antimycobacterial drugs
0.000 0.994 0.006
T37.0 Sulphonamides
0.000 0.994 0.006
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.994 0.006
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.994 0.006
T47.4 Other laxatives
0.000 0.994 0.006
T47.2 Stimulant laxatives
0.000 0.994 0.006
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.994 0.006
T45.0 Antiallergic and antiemetic drugs
0.000 0.994 0.006
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.994 0.006
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.994 0.006
K62.1 Rectal polyp
0.000 0.994 0.006
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.994 0.005
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.994 0.005
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.994 0.005
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.994 0.005
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.994 0.005
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.994 0.005
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.994 0.005
T44.0 Anticholinesterase agents
0.000 0.994 0.005
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.994 0.005
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock
0.005 0.995 0.000
F60.9 Personality disorder, unspecified
0.000 0.995 0.005
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.995 0.005
F60-F69 Disorders of adult personality and behaviour
0.000 0.995 0.005
T47.6 Antidiarrhoeal drugs
0.000 0.995 0.005
F60 Specific personality disorders
0.000 0.995 0.005
C71.1 Frontal lobe
0.000 0.995 0.005
T36.9 Systemic antibiotic, unspecified
0.000 0.995 0.005
T36.8 Other systemic antibiotics
0.000 0.995 0.005
T36.7 Antifungal antibiotics, systemically used
0.000 0.995 0.005
T36.6 Rifamycins
0.000 0.995 0.005
T36.5 Aminoglycosides
0.000 0.995 0.005
T36.3 Macrolides
0.000 0.995 0.005
T36.2 Chloramphenicol group
0.000 0.995 0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.995 0.005
F69 Unspecified disorder of adult personality and behaviour
0.000 0.995 0.005
T50.7 Analeptics and opioid receptor antagonists
0.000 0.995 0.005
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.995 0.005
T50.5 Appetite depressants
0.000 0.995 0.005
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.995 0.005
T50.1 Loop [high-ceiling] diuretics
0.000 0.995 0.005
T50.0 Mineralocorticoids and their antagonists
0.000 0.995 0.005
T50.8 Diagnostic agents
0.000 0.995 0.005
T50.4 Drugs affecting uric acid metabolism
0.000 0.995 0.005
I60.9 Subarachnoid haemorrhage, unspecified
0.005 0.995 0.000
D86.9 Sarcoidosis, unspecified
0.000 0.995 0.005
I60.3 Subarachnoid haemorrhage from posterior communicating artery
0.005 0.995 0.000
Chapter V Mental and behavioural disorders
0.000 0.995 0.005
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.995 0.005
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.995 0.005
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.995 0.004
Z37.2 Twins, both liveborn
0.005 0.995 0.000
I60 Subarachnoid haemorrhage
0.005 0.995 0.000
T43.9 Psychotropic drug, unspecified
0.000 0.996 0.004
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.996 0.004
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.996 0.004
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified
0.004 0.996 0.000
T36.0 Penicillins
0.000 0.996 0.004
T36.4 Tetracyclines
0.000 0.996 0.004
F60.5 Anankastic personality disorder
0.000 0.996 0.004
F60.6 Anxious [avoidant] personality disorder
0.000 0.996 0.004
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.996 0.004
F62 Enduring personality changes, not attributable to brain damage and disease
0.000 0.996 0.004
E10-E14 Diabetes mellitus
0.000 0.996 0.004
T43.6 Psychostimulants with abuse potential
0.000 0.996 0.004
I60.6 Subarachnoid haemorrhage from other intracranial arteries
0.004 0.996 0.000
F68 Other disorders of adult personality and behaviour
0.000 0.996 0.004
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.000 0.996 0.004
F65 Disorders of sexual preference
0.000 0.996 0.004
F63 Habit and impulse disorders
0.000 0.996 0.004
F61 Mixed and other personality disorders
0.000 0.996 0.004
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.000 0.996 0.004
F60.8 Other specific personality disorders
0.000 0.996 0.004
F60.4 Histrionic personality disorder
0.000 0.996 0.004
F60.2 Dissocial personality disorder
0.000 0.996 0.004
F60.1 Schizoid personality disorder
0.000 0.996 0.004
M10.9 Gout, unspecified
0.004 0.996 0.000
F64 Gender identity disorders
0.000 0.996 0.004
F30.0 Hypomania
0.000 0.996 0.004
F60.3 Emotionally unstable personality disorder
0.000 0.996 0.004
M72.27 Plantar fascial fibromatosis-Ankle/Foot
0.004 0.996 0.000
F12.1 Harmful use
0.004 0.996 0.000
I12.0 Hypertensive renal disease with renal failure
0.000 0.996 0.004
N48.6 Balanitis xerotica obliterans
0.000 0.996 0.004
I60.4 Subarachnoid haemorrhage from basilar artery
0.004 0.996 0.000
F60.0 Paranoid personality disorder
0.000 0.996 0.004
O24.4 Diabetes mellitus arising in pregnancy
0.004 0.996 0.000
O41.0 Oligohydramnios
0.004 0.996 0.000
F99-F99 Unspecified mental disorder
0.000 0.996 0.004
F70-F79 Mental retardation
0.000 0.996 0.004
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome
0.000 0.996 0.004
F60.7 Dependent personality disorder
0.000 0.996 0.004
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.996 0.004
S32.00 Fracture of lumbar vertebra (closed)
0.000 0.996 0.004
M10.90 Gout, unspecified (Multiple sites)
0.004 0.996 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.996 0.004
I60.2 Subarachnoid haemorrhage from anterior communicating artery
0.004 0.996 0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation
0.003 0.996 0.000
D86 Sarcoidosis
0.000 0.996 0.004
M10.92 Gout, unspecified (Upper arm)
0.003 0.996 0.000
I60.5 Subarachnoid haemorrhage from vertebral artery
0.003 0.996 0.000
D86.1 Sarcoidosis of lymph nodes
0.000 0.997 0.003
I12.9 Hypertensive renal disease without renal failure
0.000 0.997 0.003
F30 Manic episode
0.000 0.997 0.003
I60.8 Other subarachnoid haemorrhage
0.003 0.997 0.000
F62.9 Enduring personality change, unspecified
0.000 0.997 0.003
O04.9 Complete or unspecified, without complication
0.000 0.997 0.003
T39.1 4-Aminophenol derivatives
0.000 0.997 0.003
F62.8 Other enduring personality changes
0.000 0.997 0.003
F62.1 Enduring personality change after psychiatric illness
0.000 0.997 0.003
F62.0 Enduring personality change after catastrophic experience
0.000 0.997 0.003
E12 Malnutrition-related diabetes mellitus
0.000 0.997 0.003
F63.9 Habit and impulse disorder, unspecified
0.000 0.997 0.003
F63.8 Other habit and impulse disorders
0.000 0.997 0.003
F63.3 Trichotillomania
0.000 0.997 0.003
F63.2 Pathological stealing [kleptomania]
0.000 0.997 0.003
F63.1 Pathological fire-setting [pyromania]
0.000 0.997 0.003
F63.0 Pathological gambling
0.000 0.997 0.003
F65.9 Disorder of sexual preference, unspecified
0.000 0.997 0.003
F65.8 Other disorders of sexual preference
0.000 0.997 0.003
F65.6 Multiple disorders of sexual preference
0.000 0.997 0.003
F65.5 Sadomasochism
0.000 0.997 0.003
F65.4 Paedophilia
0.000 0.997 0.003
F65.3 Voyeurism
0.000 0.997 0.003
F65.2 Exhibitionism
0.000 0.997 0.003
F65.1 Fetishistic transvestism
0.000 0.997 0.003
F65.0 Fetishism
0.000 0.997 0.003
F66.9 Psychosexual development disorder, unspecified
0.000 0.997 0.003
F66.8 Other psychosexual development disorders
0.000 0.997 0.003
F66.2 Sexual relationship disorder
0.000 0.997 0.003
F66.1 Egodystonic sexual orientation
0.000 0.997 0.003
F66.0 Sexual maturation disorder
0.000 0.997 0.003
F68.8 Other specified disorders of adult personality and behaviour
0.000 0.997 0.003
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]
0.000 0.997 0.003
F68.0 Elaboration of physical symptoms for psychological reasons
0.000 0.997 0.003
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.000 0.997 0.003
M10.98 Gout, unspecified (Other)
0.003 0.997 0.000
M10.95 Gout, unspecified (Pelvic region and thigh)
0.003 0.997 0.000
M10.91 Gout, unspecified (Shoulder region)
0.003 0.997 0.000
F64.9 Gender identity disorder, unspecified
0.000 0.997 0.003
F64.8 Other gender identity disorders
0.000 0.997 0.003
F64.2 Gender identity disorder of childhood
0.000 0.997 0.003
F64.1 Dual-role transvestism
0.000 0.997 0.003
L85.9 Epidermal thickening, unspecified
0.003 0.997 0.000
C69 Malignant neoplasm of eye and adnexa
0.000 0.997 0.003
E13 Other specified diabetes mellitus
0.000 0.997 0.003
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)
0.000 0.997 0.003
D86.8 Sarcoidosis of other and combined sites
0.000 0.997 0.003
I12 Hypertensive renal disease
0.000 0.997 0.003
F64.0 Transsexualism
0.000 0.997 0.003
F79 Unspecified mental retardation
0.000 0.997 0.003
L98.4 Chronic ulcer of skin, not elsewhere classified
0.000 0.997 0.003
C70 Malignant neoplasm of meninges
0.000 0.997 0.003
F99 Mental disorder, not otherwise specified
0.000 0.997 0.003
F78 Other mental retardation
0.000 0.997 0.003
F73 Profound mental retardation
0.000 0.997 0.003
F72 Severe mental retardation
0.000 0.997 0.003
F71 Moderate mental retardation
0.000 0.997 0.003
F70 Mild mental retardation
0.000 0.997 0.003
F30-F39 Mood [affective] disorders
0.000 0.997 0.003
F80-F89 Disorders of psychological development
0.000 0.997 0.003
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.997 0.003
F95 Tic disorders
0.000 0.997 0.003
F94 Disorders of social functioning with onset specific to childhood and adolescence
0.000 0.997 0.003
F93 Emotional disorders with onset specific to childhood
0.000 0.997 0.003
F92 Mixed disorders of conduct and emotions
0.000 0.997 0.003
F91 Conduct disorders
0.000 0.997 0.003
F90 Hyperkinetic disorders
0.000 0.997 0.003
D86.3 Sarcoidosis of skin
0.000 0.997 0.003
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.000 0.997 0.003
R22.3 Localised swelling, mass and lump, upper limb
0.003 0.997 0.000
F39 Unspecified mood [affective] disorder
0.000 0.997 0.003
D86.0 Sarcoidosis of lung
0.000 0.997 0.003
M72.2 Plantar fascial fibromatosis
0.003 0.997 0.000
F30.9 Manic episode, unspecified
0.000 0.997 0.003
M70.65 Trochanteric bursitis-Pelvic/Thigh
0.003 0.997 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.000 0.997 0.003
M10.94 Gout, unspecified (Hand)
0.003 0.997 0.000
M10.93 Gout, unspecified (Forearm)
0.003 0.997 0.000
C69.3 Choroid
0.000 0.997 0.003
F30.8 Other manic episodes
0.000 0.997 0.003
F30.1 Mania without psychotic symptoms
0.000 0.997 0.003
M10.97 Gout, unspecified (Ankle and foot)
0.003 0.997 0.000
M10.96 Gout, unspecified (Lower leg)
0.003 0.997 0.000
C69.0 Conjunctiva
0.000 0.997 0.002
E12.9 Without complications
0.000 0.997 0.002
E12.8 With unspecified complications
0.000 0.997 0.002
E12.7 With multiple complications
0.000 0.997 0.002
E12.6 With other specified complications
0.000 0.997 0.002
E12.5 With peripheral circulatory complications
0.000 0.997 0.002
E12.4 With neurological complications
0.000 0.997 0.002
E12.3 With ophthalmic complications
0.000 0.997 0.002
E12.2 With renal complications
0.000 0.997 0.002
E12.1 With ketoacidosis
0.000 0.997 0.002
E12.0 With coma
0.000 0.997 0.002
C72.9 Central nervous system, unspecified
0.000 0.997 0.002
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.000 0.997 0.002
C72.5 Other and unspecified cranial nerves
0.000 0.997 0.002
C72.4 Acoustic nerve
0.000 0.997 0.002
C72.3 Optic nerve
0.000 0.997 0.002
C72.2 Olfactory nerve
0.000 0.997 0.002
C72.1 Cauda equina
0.000 0.997 0.002
C72.0 Spinal cord
0.000 0.997 0.002
I60.1 Subarachnoid haemorrhage from middle cerebral artery
0.002 0.997 0.000
C69.9 Eye, unspecified
0.000 0.997 0.002
C69.8 Overlapping lesion of eye and adnexa
0.000 0.997 0.002
C69.5 Lachrymal gland and duct
0.000 0.997 0.002
C69.4 Ciliary body
0.000 0.997 0.002
C69.1 Cornea
0.000 0.997 0.002
O41.8 Other specified disorders of amniotic fluid and membranes
0.002 0.997 0.000
E13.8 With unspecified complications
0.000 0.997 0.002
E13.7 With multiple complications
0.000 0.997 0.002
E13.6 With other specified complications
0.000 0.997 0.002
E13.5 With peripheral circulatory complications
0.000 0.997 0.002
E13.4 With neurological complications
0.000 0.997 0.002
E13.2 With renal complications
0.000 0.997 0.002
E13.1 With ketoacidosis
0.000 0.997 0.002
E13.0 With coma
0.000 0.997 0.002
E13.3 With ophthalmic complications
0.000 0.998 0.002
F79.9 Unspecified mental retardation (Without mention of impairment of behaviour)
0.000 0.998 0.002
L85.8 Other specified epidermal thickening
0.002 0.998 0.000
F34 Persistent mood [affective] disorders
0.000 0.998 0.002
F30.2 Mania with psychotic symptoms
0.000 0.998 0.002
F79.8 Unspecified mental retardation (Other impairments of behaviour)
0.000 0.998 0.002
F79.1 Unspecified mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.998 0.002
F79.0 Unspecified mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.998 0.002
S62.61 Fracture of other finger (open)
0.002 0.998 0.000
C70.9 Meninges, unspecified
0.000 0.998 0.002
C70.1 Spinal meninges
0.000 0.998 0.002
M10 Gout
0.002 0.998 0.000
F70.9 Mild mental retardation (Without mention of impairment of behaviour)
0.000 0.998 0.002
F70.8 Mild mental retardation (Other impairments of behaviour)
0.000 0.998 0.002
F70.1 Mild mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.998 0.002
F70.0 Mild mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.998 0.002
F71.9 Moderate mental retardation (Without mention of impairment of behaviour)
0.000 0.998 0.002
F71.8 Moderate mental retardation (Other impairments of behaviour)
0.000 0.998 0.002
F71.1 Moderate mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.998 0.002
F71.0 Moderate mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.998 0.002
F72.9 Severe mental retardation (Without mention of impairment of behaviour)
0.000 0.998 0.002
F72.8 Severe mental retardation (Other impairments of behaviour)
0.000 0.998 0.002
F72.1 Severe mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.998 0.002
F72.0 Severe mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.998 0.002
F73.9 Profound mental retardation (Without mention of impairment of behaviour)
0.000 0.998 0.002
F73.8 Profound mental retardation (Other impairments of behaviour)
0.000 0.998 0.002
F73.1 Profound mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.998 0.002
F73.0 Profound mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.998 0.002
F78.9 Other mental retardation (Without mention of impairment of behaviour)
0.000 0.998 0.002
F78.8 Other mental retardation (Other impairments of behaviour)
0.000 0.998 0.002
F78.1 Other mental retardation (Significant impairment of behaviour requiring attention or treatment)
0.000 0.998 0.002
F78.0 Other mental retardation (With the statement of no, or minimal, impairment of behaviour)
0.000 0.998 0.002
F38 Other mood [affective] disorders
0.000 0.998 0.002
C69.6 Orbit
0.000 0.998 0.002
G70.0 Myasthenia gravis
0.000 0.998 0.002
F89 Unspecified disorder of psychological development
0.000 0.998 0.002
F88 Other disorders of psychological development
0.000 0.998 0.002
F83 Mixed specific developmental disorders
0.000 0.998 0.002
F82 Specific developmental disorder of motor function
0.000 0.998 0.002
F90.9 Hyperkinetic disorder, unspecified
0.000 0.998 0.002
F90.8 Other hyperkinetic disorders
0.000 0.998 0.002
F90.1 Hyperkinetic conduct disorder
0.000 0.998 0.002
F90.0 Disturbance of activity and attention
0.000 0.998 0.002
F91.9 Conduct disorder, unspecified
0.000 0.998 0.002
F91.8 Other conduct disorders
0.000 0.998 0.002
F91.3 Oppositional defiant disorder
0.000 0.998 0.002
F91.2 Socialised conduct disorder
0.000 0.998 0.002
F91.1 Unsocialised conduct disorder
0.000 0.998 0.002
F91.0 Conduct disorder confined to the family context
0.000 0.998 0.002
F92.9 Mixed disorder of conduct and emotions, unspecified
0.000 0.998 0.002
F92.8 Other mixed disorders of conduct and emotions
0.000 0.998 0.002
F92.0 Depressive conduct disorder
0.000 0.998 0.002
F93.9 Childhood emotional disorder, unspecified
0.000 0.998 0.002
F93.8 Other childhood emotional disorders
0.000 0.998 0.002
F93.3 Sibling rivalry disorder
0.000 0.998 0.002
F93.2 Social anxiety disorder of childhood
0.000 0.998 0.002
F93.1 Phobic anxiety disorder of childhood
0.000 0.998 0.002
F93.0 Separation anxiety disorder of childhood
0.000 0.998 0.002
F94.9 Childhood disorder of social functioning, unspecified
0.000 0.998 0.002
F94.8 Other childhood disorders of social functioning
0.000 0.998 0.002
F94.2 Disinhibited attachment disorder of childhood
0.000 0.998 0.002
F94.1 Reactive attachment disorder of childhood
0.000 0.998 0.002
F94.0 Elective mutism
0.000 0.998 0.002
F95.9 Tic disorder, unspecified
0.000 0.998 0.002
F95.8 Other tic disorders
0.000 0.998 0.002
F95.2 Combined vocal and multiple motor tic disorder [de la Tourette]
0.000 0.998 0.002
F95.1 Chronic motor or vocal tic disorder
0.000 0.998 0.002
F95.0 Transient tic disorder
0.000 0.998 0.002
F98.9 Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.998 0.002
F98.8 Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.000 0.998 0.002
F98.6 Cluttering
0.000 0.998 0.002
F98.5 Stuttering [stammering]
0.000 0.998 0.002
F98.4 Stereotyped movement disorders
0.000 0.998 0.002
F98.3 Pica of infancy and childhood
0.000 0.998 0.002
F98.2 Feeding disorder of infancy and childhood
0.000 0.998 0.002
F98.1 Nonorganic encopresis
0.000 0.998 0.002
F98.0 Nonorganic enuresis
0.000 0.998 0.002
F12 Mental and behavioural disorders due to use of cannabinoids
0.002 0.998 0.000
O41 Other disorders of amniotic fluid and membranes
0.002 0.998 0.000
E13.9 Without complications
0.000 0.998 0.002
A63.0 Anogenital (venereal) warts
0.002 0.998 0.000
F51 Nonorganic sleep disorders
0.000 0.998 0.002
M72.14 Knuckle pads (Hand)
0.002 0.998 0.000
M10.0 Idiopathic gout
0.002 0.998 0.000
M72.29 Plantar fascial fibromatosis-Site unspec
0.002 0.998 0.000
M72.28 Plantar fascial fibromatosis-Other
0.002 0.998 0.000
M72.26 Plantar fascial fibromatosis-Lower Leg
0.002 0.998 0.000
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh
0.002 0.998 0.000
M72.24 Plantar fascial fibromatosis-Hand
0.002 0.998 0.000
M72.23 Plantar fascial fibromatosis-Forearm
0.002 0.998 0.000
M72.22 Plantar fascial fibromatosis-Upper arm
0.002 0.998 0.000
M72.21 Plantar fascial fibromatosis-Shldr region
0.002 0.998 0.000
M72.20 Plantar fascial fibromatosis-Mult sites
0.002 0.998 0.000
M70.6 Trochanteric bursitis
0.002 0.998 0.000
F84 Pervasive developmental disorders
0.000 0.998 0.002
L85 Other epidermal thickening
0.002 0.998 0.000
F12.2 Dependence syndrome
0.002 0.998 0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.000 0.998 0.002
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.000 0.998 0.002
F55 Abuse of non-dependence-producing substances
0.000 0.998 0.002
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.000 0.998 0.002
Z35.0 Supervision of pregnancy with history of infertility
0.002 0.998 0.000
F80 Specific developmental disorders of speech and language
0.001 0.998 0.001
M54.36 Sciatica (Lumbar region)
0.000 0.998 0.002
G06.2 Extradural and subdural abscess, unspecified
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.